Cellular and Molecular Life SciencesCell BiologyPeer-reviewed journal article
Boldine prevents diabetes-induced skeletal muscle dysfunction by inhibiting large-pore channels
Walter VásqueziD, Andrea Lira, Felipe TroncosoiD, Hermes SandovaliD, Luis A. Cea, Xavier F. FigueroaiD, Carlos EscuderoiD, Juan Carlos SáeziD
Abstract
BackgroundDiabetes mellitus leads to skeletal muscle dysfunction associated with loss of strength, impaired blood perfusion, lipid accumulation, and inflammation. The opening of large-pore channels has been linked to increased membrane permeability and inflammatory signaling in several pathologies. Boldine, an alkaloid from Peumus boldus, blocks large-pore channel activity and exhibits antioxidant and anti-inflammatory properties. This study evaluated whether boldine prevents skeletal muscle alterations induced by diabetes and explored potential underlying mechanisms. MethodsDiabetes was induced in male C57BL/6J mice using streptozotocin (STZ, 40 mg/kg/day for 5 days). Diabetic mice were treated with boldine (50 mg/kg/day) for four weeks. Muscle strength and resting membrane potential were analyzed in vivo. Also, right gastrocnemius muscle blood perfusion at basal and after acetylcholine (10 M) stimulation were analyzed in vivo. Lipid accumulation was assessed using Oil Red O staining, and CD31 immunodetection was used to evaluate capillary density. mRNA levels of NLRP3 were evaluated in muscle by qPCR. In human myoblasts (AB1167) cultured under low (8 mM) or high glucose (25 mM) conditions, with or without boldine, membrane permeability (ethidium uptake), intracellular Ca{superscript 2} (Fura-2), nitric oxide (DAF-FM), and levels of NLRP3 and Casp1 (qPCR) and reactivity PPAR{gamma} (Immunofluorescence) were determined. ResultsSTZ mice showed reduced muscle strength and depolarized resting membrane potential, both prevented by boldine. Basal muscle perfusion was [~]20% lower in diabetic mice (160.1 {+/-} 17.2 vs. 199.1 {+/-} 13.8 units), whereas boldine preserved perfusion (184.6 {+/-} 14.3 units). Oil Red O-positive fibers increased to 52.4 {+/-} 3.6% in diabetic mice and decreased to 15.2 {+/-} 4.1% with boldine (control: 3.1 {+/-} 1.3%; p View larger version (25K): org.highwire.dtl.DTLVardef@19179b4org.highwire.dtl.DTLVardef@1cd3d21org.highwire.dtl.DTLVardef@16851d6org.highwire.dtl.DTLVardef@1d4e77c_HPS_FORMAT_FIGEXP M_FIG C_FIG
- organism: mouse
- organism: human
- assay: proteomics
- assay: metabolomics
- assay: imaging
- research focus: cell type annotation
- research focus: differential expression
- research focus: cell signaling & trafficking
- approach: experimental assay
- Citations
- 0
- FWCI
- 0.00
- Field percentile
- 10th percentile
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Microvascular homeostasis is compromised in pancreatic islets in a mouse model of beta cell loss and low-grade inflammation
Luciana Mateus Gonçalves, Isha S. Shirvaikar, … Joana Almaça·DiabetesPeer-reviewed·Oct 28, 2025
- Effect of insulin insufficiency on ultrastructure and function in skeletal muscle
C. Kopecky, M. Haug, … B. J. Cochran·bioRxiv·Dec 18, 2022
- Propionate ameliorates diabetes-induced neurological dysfunction through regulating the PI3K/Akt/eNOS signaling pathway
- Loss of ATP-sensitive channel expression and function decreases opioid sensitivity in a mouse model of type 2 diabetes
Cole Fisher, Kayla Johnson, … Amanda H. Klein·bioRxiv·Sep 6, 2023
- Inhibition of MMP 2 protects the endothelial glycocalyx and improves diastolic function in diabetic cardiomyopathy
S. Buffonge, Y. Qiu, … S. C. Satchell·bioRxiv·Dec 18, 2023
- Schwann cell dysfunction contributes to diabetic wound pathology which is partially ameliorated by oncostatin M treatment
Shahreen Mahbub Rahman, Griffen Wakelin, … Adam Patrick William Johnston·bioRxiv·Apr 14, 2026